Transcutaneous vagus nerve stimulation in patients with attention-deficit/hyperactivity disorder: A viable option?
Zaehle T, Krauel K
Progress in brain research · 2021
Key finding
At the system level, reduced availability of the neurotransmitters dopamine (DA) and norepinephrine (NE) but also γ-aminobutyric acid (GABA) have been repeatedly demonstrated.
- Condition
- ADHD
- Stimulation
- taVNS
- Evidence tier
- Controlled Clinical Trial
- Participants
- —
Cite this study
Zaehle, T., & Krauel, K. (2021). Transcutaneous vagus nerve stimulation in patients with attention-deficit/hyperactivity disorder: A viable option?. Progress in brain research. https://doi.org/10.1016/bs.pbr.2021.03.001
Related studies in ADHD
Towards optimizing target engagement in non-invasive trigeminal nerve stimulation: anatomical characterization of the human trigeminal nerve
Perrault et al. · Journal of neural engineering · 2025 · Controlled Clinical Trial
Transcutaneous auricular vagus nerve stimulation as a potential therapy for attention deficit hyperactivity disorder: modulation of the noradrenergic pathway in the prefrontal lobe
Zhi et al. · Frontiers in neuroscience · 2024 · Controlled Clinical Trial
Epilepsy Disorders and Treatment Modalities
Kaeberle · NASN school nurse (Print) · 2018 · Controlled Clinical Trial
Emerging brain-based interventions for children and adolescents: overview and clinical perspective
Hirshberg et al. · Child and adolescent psychiatric clinics of North America · 2005 · Controlled Clinical Trial
Summary by Vagus Research. Always consult the primary source for the authoritative record.